Takeda Pharmaceutical (TAK) said Thursday that Orzeyful, or oveporexton, is now available in the US for the treatment of narcolepsy type 1 in adults.
The drug is available by prescription from licensed healthcare providers and will be dispensed across the country through Accredo Specialty Pharmacy, part of Cigna Group (CI) subsidiary Evernorth Health Services, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments